Kodiak Sciences (KOD)

• Market cap: $957M
• 1 day: -13.87%
• 5 days: -5.62%
• 1 month: 10.75%
• 3 months: 175.53%
• 6 months: 315.83%
• Year to date: 110.32%
• 1 year: 377.11%
• 5 years: -80.09%
• 10 years: 78.44%
• Sector: Healthcare
• Industry: Biotechnology

About: Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Employees: 121